$CLX
CLOROX CO /DE/

2014 Q4 Form 10-Q Financial Statement

#000120677415000394 Filed on February 05, 2015

View on sec.gov

Income Statement

Concept 2014 Q4 2013 Q4
Revenue $1.345B $1.308B
YoY Change 2.83% -1.28%
Cost Of Revenue $773.0M $753.0M
YoY Change 2.66% 1.35%
Gross Profit $572.0M $555.0M
YoY Change 3.06% -1.42%
Gross Profit Margin 42.53% 42.43%
Selling, General & Admin $191.0M $196.0M
YoY Change -2.55% -3.92%
% of Gross Profit 33.39% 35.32%
Research & Development $33.00M $31.00M
YoY Change 6.45% 0.0%
% of Gross Profit 5.77% 5.59%
Depreciation & Amortization $42.00M $45.00M
YoY Change -6.67% -2.17%
% of Gross Profit 7.34% 8.11%
Operating Expenses $224.0M $227.0M
YoY Change -1.32% -3.4%
Operating Profit $348.0M $328.0M
YoY Change 6.1% 0.0%
Interest Expense $26.00M $26.00M
YoY Change 0.0% -21.21%
% of Operating Profit 7.47% 7.93%
Other Income/Expense, Net
YoY Change
Pretax Income $197.0M $184.0M
YoY Change 7.07% -2.13%
Income Tax $69.00M $66.00M
% Of Pretax Income 35.03% 35.87%
Net Earnings $125.0M $115.0M
YoY Change 8.7% -6.5%
Net Earnings / Revenue 9.29% 8.79%
Basic Earnings Per Share $0.96 $0.89
Diluted Earnings Per Share $0.95 $0.87
COMMON SHARES
Basic Shares Outstanding 130.6M shares 129.8M shares
Diluted Shares Outstanding 132.8M shares 132.3M shares

Balance Sheet

Concept 2014 Q4 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $819.0M $341.0M
YoY Change 140.18% -23.37%
Cash & Equivalents $819.0M $341.0M
Short-Term Investments
Other Short-Term Assets $167.0M $194.0M
YoY Change -13.92% 27.63%
Inventory $446.0M $466.0M
Prepaid Expenses
Receivables $473.0M $499.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.905B $1.500B
YoY Change 27.0% -3.35%
LONG-TERM ASSETS
Property, Plant & Equipment $933.0M $992.0M
YoY Change -5.95% -5.61%
Goodwill $1.080B $1.100B
YoY Change -1.82% -1.7%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $164.0M $177.0M
YoY Change -7.34% 22.07%
Total Long-Term Assets $2.769B $2.888B
YoY Change -4.12% -2.1%
TOTAL ASSETS
Total Short-Term Assets $1.905B $1.500B
Total Long-Term Assets $2.769B $2.888B
Total Assets $4.674B $4.388B
YoY Change 6.52% -2.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $375.0M $359.0M
YoY Change 4.46% -1.64%
Accrued Expenses $492.0M $480.0M
YoY Change 2.5% -2.64%
Deferred Revenue
YoY Change
Short-Term Debt $2.000M $342.0M
YoY Change -99.42% 6740.0%
Long-Term Debt Due $875.0M
YoY Change
Total Short-Term Liabilities $1.744B $1.181B
YoY Change 47.67% -13.98%
LONG-TERM LIABILITIES
Long-Term Debt $1.795B $2.170B
YoY Change -17.28% 0.05%
Other Long-Term Liabilities $773.0M $765.0M
YoY Change 1.05% -2.92%
Total Long-Term Liabilities $2.568B $2.935B
YoY Change -12.5% -0.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.744B $1.181B
Total Long-Term Liabilities $2.568B $2.935B
Total Liabilities $4.393B $4.232B
YoY Change 3.8% -4.81%
SHAREHOLDERS EQUITY
Retained Earnings $1.757B $1.623B
YoY Change 8.26% 13.5%
Common Stock $885.0M $852.0M
YoY Change 3.87% 6.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.908B $1.932B
YoY Change -1.24% 7.27%
Treasury Stock Shares 27.77M shares 28.88M shares
Shareholders Equity $281.0M $156.0M
YoY Change
Total Liabilities & Shareholders Equity $4.674B $4.388B
YoY Change 6.52% -2.53%

Cashflow Statement

Concept 2014 Q4 2013 Q4
OPERATING ACTIVITIES
Net Income $125.0M $115.0M
YoY Change 8.7% -6.5%
Depreciation, Depletion And Amortization $42.00M $45.00M
YoY Change -6.67% -2.17%
Cash From Operating Activities $34.00M $32.00M
YoY Change 6.25% -72.65%
INVESTING ACTIVITIES
Capital Expenditures -$31.00M -$36.00M
YoY Change -13.89% -25.0%
Acquisitions
YoY Change
Other Investing Activities $1.000M $1.000M
YoY Change 0.0% -99.07%
Cash From Investing Activities -$30.00M -$35.00M
YoY Change -14.29% -158.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 465.0M 25.00M
YoY Change 1760.0% -106.3%
NET CHANGE
Cash From Operating Activities 34.00M 32.00M
Cash From Investing Activities -30.00M -35.00M
Cash From Financing Activities 465.0M 25.00M
Net Change In Cash 469.0M 22.00M
YoY Change 2031.82% -110.0%
FREE CASH FLOW
Cash From Operating Activities $34.00M $32.00M
Capital Expenditures -$31.00M -$36.00M
Free Cash Flow $65.00M $68.00M
YoY Change -4.41% -58.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.48
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4000000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.63
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
115000000 USD
CY2013Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
96000000 USD
CY2014Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound
30000000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
11000000 USD
clx Remediation Period
RemediationPeriod
P30Y
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.44
clx Site Contingency Agreed Percentage Of Cost Sharing
SiteContingencyAgreedPercentageOfCostSharing
0.243 pure
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
179000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2697000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-58000000 USD
us-gaap Net Income Loss
NetIncomeLoss
215000000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.10
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.07
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129933000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132203000 shares
clx Earnings Losses From Continuing Operations Before Income Taxes
EarningsLossesFromContinuingOperationsBeforeIncomeTaxes
415000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
191000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
125000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
281000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
490000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
273000000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
10000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
277000000 USD
clx Interest Rate Forward Contracts Settlement
InterestRateForwardContractsSettlement
25000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
496000000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-23000000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-3000000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1547000000 USD
us-gaap Gross Profit
GrossProfit
1150000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
371000000 USD
us-gaap Advertising Expense
AdvertisingExpense
248000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63000000 USD
us-gaap Interest Expense
InterestExpense
52000000 USD
clx Other Income Expense Net
OtherIncomeExpenseNet
1000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
142000000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
267000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-3000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-141000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
8000000 USD
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
88000000 USD
CY2014Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;"><strong>Basis of Presentation</strong></font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">&#160;</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">The unaudited interim condensed consolidated financial statements for the three and six months ended December 31, 2014 and <font>2013</font>, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of The Clorox Company and its subsidiaries (the Company) for the periods presented. The results for the interim period ended December 31, 2014, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2015, or for any other future period.</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">&#160;</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">Effective September 22, 2014, the Company's Venezuela affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox Venezuela) discontinued its operations. Consequently, for the three and six months ended December 31, 2014 and <font>2013</font>, Clorox Venezuela is reflected as a discontinued operation in the Company's financial statements.</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">&#160;</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The information in this report should be read in conjunction with the Company's audited financial statements for the fiscal year ended June 30, 2014, which includes a complete set of footnote disclosures, including the Company's significant accounting policies, filed with the SEC in Exhibit 99.2 of the Company's Current Report on Form 8-K on December 4, 2014.</font></p> </div>
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;"><strong>Recently Issued Accounting Pronouncements</strong></font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">&#160;</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: arial, helvetica, sans-serif; font-size: 11pt;">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &#147;Revenue from Contracts with Customers (Topic 606),&#148; which replaces most existing U.S. GAAP revenue recognition guidance and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional disclosures about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including information about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the first quarter of fiscal year 2018, with no early adoption permitted. The Company is currently evaluating the impact the adoption of ASU 2014-09 will have on its consolidated financial statements.</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">&#160;</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-size: 11pt; font-family: arial, helvetica, sans-serif;">In April 2014, the FASB issued ASU No <font>2014</font>-<font>08</font> &#147;Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (Topic <font>205</font>)&#148;, which will change the criteria for reporting discontinued operations. The amendments will also require new disclosures about discontinued operations and disposals of components of an entity that do not qualify for discontinued operations reporting. The amendments are effective for the Company for new disposals (or classifications as held for sale) of components of the Company, should they occur, beginning in the first quarter of fiscal year <font>2016</font>. Early adoption is permitted for disposals (or classifications as held for sale) that have not been previously reported. The Company will adopt this ASU beginning in the first quarter of fiscal year <font>2016</font>, as required. Adoption of the new standard will not impact the Company's reporting or disclosures for discontinued operations of Clorox Venezuela.</font></p> </div>
CY2014Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 USD
CY2014Q4 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-19000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-16000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-60000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
78000000 USD
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-19000000 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
125000000 USD
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3000000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
128000000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2270000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2014Q4 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 USD
CY2014Q4 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-18000000 USD
CY2014Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.349 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.342 pure
us-gaap Depreciation And Amortization
DepreciationAndAmortization
85000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-1000000 USD
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130555000 shares
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
1345000000 USD
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
773000000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
13000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-23000000 USD
us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
4000000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-73000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-30000000 USD
clx Reclassification From Accumulated Other Comprehensive Income Other Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeOtherCurrentPeriodNetOfTax
-7000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-6000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
0 USD
CY2014Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132819000 shares
CY2014Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2264000 shares
CY2014Q4 us-gaap Gross Profit
GrossProfit
572000000 USD
CY2014Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
191000000 USD
CY2014Q4 us-gaap Advertising Expense
AdvertisingExpense
127000000 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-19000000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-20000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-3000000 USD
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-3000000 USD
CY2014Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-3000000 USD
CY2014Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
0 USD
CY2014Q4 us-gaap Interest Expense
InterestExpense
26000000 USD
CY2014Q4 clx Other Income Expense Net
OtherIncomeExpenseNet
-2000000 USD
CY2014Q4 clx Earnings Losses From Continuing Operations Before Income Taxes
EarningsLossesFromContinuingOperationsBeforeIncomeTaxes
197000000 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
69000000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.98
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.96
CY2014Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.97
CY2014Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
CY2014Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.74
CY2014Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2014Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2014Q4 dei Document Type
DocumentType
10-Q
CY2014Q4 dei Amendment Flag
AmendmentFlag
false
CY2014Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2014Q4 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q4 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q4 dei Entity Registrant Name
EntityRegistrantName
CLOROX CO /DE/
CY2014Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000021076
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
1308000000 USD
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
753000000 USD
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2013Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2442000 shares
CY2013Q4 us-gaap Gross Profit
GrossProfit
555000000 USD
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
196000000 USD
CY2013Q4 us-gaap Advertising Expense
AdvertisingExpense
122000000 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31000000 USD
CY2013Q4 us-gaap Interest Expense
InterestExpense
26000000 USD
CY2013Q4 clx Other Income Expense Net
OtherIncomeExpenseNet
-4000000 USD
CY2013Q4 clx Earnings Losses From Continuing Operations Before Income Taxes
EarningsLossesFromContinuingOperationsBeforeIncomeTaxes
184000000 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
118000000 USD
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3000000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.91
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
CY2013Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.90
CY2013Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129836000 shares
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132278000 shares
CY2013Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.71
CY2013Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.356 pure
CY2013Q4 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
4000000 USD
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q4 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 USD
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23000000 USD
CY2013Q4 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
3000000 USD
CY2013Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000000 USD
CY2013Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19000000 USD
CY2013Q4 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
1000000 USD
CY2013Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2000000 USD
CY2013Q4 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
-1000000 USD
CY2014Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2755000000 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15000000 USD
CY2014Q4 clx Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits
DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits
9000000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-453000000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
819000000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
61000000 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1809000000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158741461 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
130968651 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27772810 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 clx Employee Benefit Obligations Noncurrent
EmployeeBenefitObligationsNoncurrent
286000000 USD
CY2014Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
79000000 USD
CY2014Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
116000000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
773000000 USD
CY2014Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
473000000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
446000000 USD
CY2014Q2 us-gaap Commercial Paper
CommercialPaper
143000000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
1080000000 USD
CY2014Q4 clx Trademarks Net
TrademarksNet
537000000 USD
CY2014Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
55000000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
164000000 USD
CY2014Q4 us-gaap Assets
Assets
4674000000 USD
CY2014Q4 us-gaap Commercial Paper
CommercialPaper
2000000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
875000000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
159000000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
726000000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1757000000 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
167000000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1905000000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
933000000 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
375000000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
492000000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1744000000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1795000000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
81000000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
4393000000 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1908000000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
281000000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4674000000 USD
CY2014Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
13000000 USD
CY2014Q4 clx Current Value Of Judgment
CurrentValueOfJudgment
34000000 USD
CY2014Q4 us-gaap Loss Contingency Range Of Possible Loss Maximum
LossContingencyRangeOfPossibleLossMaximum
28000000 USD
CY2014Q4 us-gaap Loss Contingency Range Of Possible Loss Minimum
LossContingencyRangeOfPossibleLossMinimum
0 USD
CY2014Q4 clx Letter Of Credit Borrowing Capacity
LetterOfCreditBorrowingCapacity
11000000 USD
CY2014Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
0 USD
CY2014Q4 clx Venture Agreement Net Terminal Obligation
VentureAgreementNetTerminalObligation
292000000 USD
CY2014Q4 clx Low Income Housing Partnerships Investment
LowIncomeHousingPartnershipsInvestment
1000000 USD
CY2014Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
35000000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
369000000 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
109000000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3000000 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2000000 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
108000000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
312000000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
386000000 USD
CY2014Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
36000000 USD
CY2014Q2 clx Low Income Housing Partnerships Investment
LowIncomeHousingPartnershipsInvestment
4000000 USD
CY2014Q2 clx Venture Agreement Net Terminal Obligation
VentureAgreementNetTerminalObligation
290000000 USD
CY2014Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
14000000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
329000000 USD
CY2014Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
546000000 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
134000000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
1395000000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
977000000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
1101000000 USD
CY2014Q2 clx Trademarks Net
TrademarksNet
547000000 USD
CY2014Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
64000000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000000 USD
CY2014Q2 us-gaap Assets
Assets
4258000000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
768000000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
103000000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
4104000000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
159000000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
709000000 USD
CY2014Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
113000000 USD
CY2014Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
76000000 USD
CY2014Q2 clx Employee Benefit Obligations Noncurrent
EmployeeBenefitObligationsNoncurrent
289000000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.90
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
575000000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
440000000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
472000000 USD
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
8000000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1638000000 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1595000000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1739000000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2036000000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-417000000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
154000000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4258000000 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
29945233 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158741461 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
128796228 shares
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1776000000 USD
CY2014Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
11000000 USD
CY2014Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
58000000 USD
CY2014Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
17000000 USD
CY2014Q2 clx Derivative Instruments Subject To Contractually Defined Counterparty Liability Position Limits
DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits
11000000 USD
CY2014Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2265000000 USD
clx Earnings Losses From Continuing Operations Before Income Taxes
EarningsLossesFromContinuingOperationsBeforeIncomeTaxes
395000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2651000000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1512000000 USD
us-gaap Gross Profit
GrossProfit
1139000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
390000000 USD
us-gaap Advertising Expense
AdvertisingExpense
242000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62000000 USD
us-gaap Interest Expense
InterestExpense
52000000 USD
clx Other Income Expense Net
OtherIncomeExpenseNet
-2000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
257000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6000000 USD
us-gaap Net Income Loss
NetIncomeLoss
251000000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.99
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.93
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.95
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129955000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132276000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.42
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
231000000 USD
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
0 USD
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
2000000 USD
clx Interest Rate Forward Contracts Settlement
InterestRateForwardContractsSettlement
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
210000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
42000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.348 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
1000000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
222000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
88000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
23000000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-77000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
72000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-77000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-65000000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-12000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
63000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
140000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
130000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
184000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-103000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2321000 shares
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
4000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
-2000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20000000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
3000000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
2000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-19000000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
341000000 USD
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131177785 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
299000000 USD

Files In Submission

Name View Source Status
0001206774-15-000394-index-headers.html Edgar Link pending
0001206774-15-000394-index.html Edgar Link pending
0001206774-15-000394.txt Edgar Link pending
0001206774-15-000394-xbrl.zip Edgar Link pending
clorox_10q.htm Edgar Link pending
clx-20141231.xml Edgar Link completed
clx-20141231.xsd Edgar Link pending
clx-20141231_cal.xml Edgar Link unprocessable
clx-20141231_def.xml Edgar Link unprocessable
clx-20141231_lab.xml Edgar Link unprocessable
clx-20141231_pre.xml Edgar Link unprocessable
exhibit10-1.htm Edgar Link pending
exhibit10-2.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending